- 米国企業
- Anika Therapeutics, Inc.
Anika Therapeutics, Inc.ANIK
| 2011年
12月31日 | 2012年
12月31日 | 2013年
12月31日 | 2014年
12月31日 | 2015年
12月31日 | 2016年
12月31日 | 2017年
12月31日 | 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 |
|---|
| Net (loss) income | 8 | 12 | 21 | 38 | 31 | 33 | 32 | 19 | 27 | -24 | 4 | -15 |
|---|
| Depreciation | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 6 | 6 | 13 | 6 | 7 |
|---|
| Amortization of acquisition related intangible assets | - | - | - | - | - | - | - | - | - | - | 8 | 8 |
|---|
| Amortization of acquisition related inventory step-up | - | - | - | - | - | - | - | - | - | 11 | 6 | - |
|---|
| Non-cash operating lease cost | - | - | - | - | - | - | - | - | - | - | 2 | 2 |
|---|
| Goodwill impairment charge | - | - | - | - | - | - | - | - | - | 43 | - | - |
|---|
| Change in fair value of contingent consideration | - | - | - | - | - | - | - | - | - | -29 | -21 | - |
|---|
| Loss on disposal of fixed assets | - | - | - | - | - | - | -0 | -0 | -1 | -0 | -1 | - |
|---|
| Loss on impairment of intangible asset | - | - | - | - | - | - | - | - | 0 | 2 | 1 | - |
|---|
| us-gaap_ShareBasedCompensation | 1 | 1 | 1 | 2 | 2 | 3 | 6 | 11 | 6 | 5 | 11 | 14 |
|---|
| Deferred income taxes | 2 | -10,269 | 2 | 815,169 | -1 | -0 | -1 | -2 | 1 | -4 | -2 | -5 |
|---|
| Provision for doubtful accounts | - | - | - | - | - | - | - | - | - | 1 | 0 | 0 |
|---|
| Provision for inventory | 1 | 1 | 171,089 | 377,753 | 0 | 1 | 1 | 4 | 2 | 5 | 7 | 5 |
|---|
| Other | - | - | - | - | - | - | - | - | - | - | 0 | - |
|---|
| Accounts receivable | 3 | 4 | -2,411,247 | -897,561 | 5 | 6 | -3 | -3 | 2 | -6 | 6 | 6 |
|---|
| Inventories | -224,714 | 2 | 3 | 2 | 3 | 2 | 7 | 8 | 6 | 14 | 7 | 7 |
|---|
| Prepaid expenses, other current and long-term assets | -947,263 | -200,453 | -204,519 | -585,452 | -0 | 1 | 1 | -1 | 2 | 2 | -1 | 1 |
|---|
| Accounts payable | -6,594,292 | -2,879,330 | 622,928 | -749,601 | 6 | -5 | 4 | -2 | 1 | 1 | -1 | 2 |
|---|
| Operating lease liabilities | - | - | - | - | - | - | - | - | -1 | -1 | -2 | -1 |
|---|
| Accrued expenses, other current and long-term liabilities | 1 | 1 | -376,897 | -1,189,096 | -0 | 2 | -1 | 1 | 4 | -0 | 4 | -0 |
|---|
| Income taxes | 450,482 | 1 | 152,364 | 9 | 5 | -4 | 0 | 1 | -1 | -2 | -1 | 1 |
|---|
| Payments of contingent consideration | - | - | - | - | - | - | - | - | - | -1 | -3 | - |
|---|
| Net cash provided by operating activities | 10 | 11 | 25 | - | 39 | 24 | 41 | 35 | 37 | 13 | 8 | 4 |
|---|
| Acquisition of Parcus Medical and Arthrosurface, net of cash acquired | - | - | - | - | - | - | - | - | - | 95 | 0 | - |
|---|
| Proceeds from maturities of investments | - | - | - | 20 | 24 | 47 | 42 | 46 | 146 | 45 | 3 | - |
|---|
| Purchases of investments | - | - | - | 27 | 45 | 39 | 45 | 92 | 104 | 20 | - | - |
|---|
| Purchases of property and equipment | 1 | 2 | 440,890 | 2 | 9 | 14 | 9 | 5 | 3 | 2 | 5 | 7 |
|---|
| Net cash (used in) provided by investing activities | -1,400,348 | -1,504,707 | -253,155 | - | -30 | -7 | -12 | -50 | 40 | -71 | -3 | -7 |
|---|
| Payments made on finance leases | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
|---|
| Proceeds from long-term debt | - | - | - | - | - | - | - | - | - | 50 | - | - |
|---|
| Repayments of long-term debt | 2 | 2 | 10 | - | - | - | - | - | - | 50 | - | - |
|---|
| Proceeds from employee stock purchase program | - | - | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Cash paid for tax withheld on vested restricted stock awards | - | - | - | 6 | - | - | - | 2 | 0 | 0 | 0 | 1 |
|---|
| Proceeds from exercises of equity awards | 160,470 | 388,675 | 3 | 2 | 1 | 1 | 0 | 3 | 22 | 2 | 1 | 0 |
|---|
| Payments of contingent consideration | - | - | - | - | - | - | - | - | - | 4 | 7 | 4 |
|---|
| Net cash used by financing activities | -1,165,340 | -758,854 | -5,689,229 | - | 2 | -23 | 0 | -29 | -8 | -4 | -7 | -5 |
|---|
| Exchange rate impact on cash | - | - | - | - | - | - | - | - | - | 0 | 0 | -0 |
|---|
| Decrease in cash and cash equivalents | - | - | - | - | - | - | - | - | - | -62 | -1 | -8 |
|---|
| Cash paid for income taxes, net of refunds | - | - | - | - | - | - | - | - | - | - | 1 | 0 |
|---|
| Right-of-use assets obtained in exchange for operating lease liabilities | - | - | - | - | - | - | - | - | - | - | 0 | 12 |
|---|
| Purchases of property and equipment included in accounts payable and accrued expenses | - | - | - | - | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
|---|
| Consideration for acquisitions included in accounts payable and accrued expenses | - | - | - | - | - | - | - | - | - | 0 | - | - |
|---|
| Contingent consideration fair value on acquisition date | - | - | - | - | - | - | - | - | - | 69 | - | - |
|---|